rs4236335

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001002010.5(NT5C3A):​c.139-603G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.712 in 152,094 control chromosomes in the GnomAD database, including 38,922 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.71 ( 38922 hom., cov: 33)

Consequence

NT5C3A
NM_001002010.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.487

Publications

7 publications found
Variant links:
Genes affected
NT5C3A (HGNC:17820): (5'-nucleotidase, cytosolic IIIA) This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. Mutations in this gene are a cause of hemolytic anemia due to uridine 5-prime monophosphate hydrolase deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and pseudogenes of this gene are located on the long arm of chromosomes 3 and 4. [provided by RefSeq, Mar 2012]
NT5C3A Gene-Disease associations (from GenCC):
  • hemolytic anemia due to pyrimidine 5' nucleotidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001002010.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.762 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001002010.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NT5C3A
NM_001002010.5
MANE Select
c.139-603G>T
intron
N/ANP_001002010.2X6RM59
NT5C3A
NM_001374335.1
c.139-3410G>T
intron
N/ANP_001361264.1
NT5C3A
NM_001002009.3
c.37-603G>T
intron
N/ANP_001002009.1Q9H0P0-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NT5C3A
ENST00000610140.7
TSL:1 MANE Select
c.139-603G>T
intron
N/AENSP00000476480.2X6RM59
NT5C3A
ENST00000456458.5
TSL:1
n.*44-603G>T
intron
N/AENSP00000389676.2F8WDR0
NT5C3A
ENST00000930183.1
c.139-603G>T
intron
N/AENSP00000600242.1

Frequencies

GnomAD3 genomes
AF:
0.712
AC:
108213
AN:
151976
Hom.:
38883
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.769
Gnomad AMI
AF:
0.504
Gnomad AMR
AF:
0.728
Gnomad ASJ
AF:
0.560
Gnomad EAS
AF:
0.489
Gnomad SAS
AF:
0.604
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.614
Gnomad NFE
AF:
0.703
Gnomad OTH
AF:
0.684
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.712
AC:
108308
AN:
152094
Hom.:
38922
Cov.:
33
AF XY:
0.713
AC XY:
52974
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.769
AC:
31936
AN:
41508
American (AMR)
AF:
0.728
AC:
11128
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.560
AC:
1942
AN:
3470
East Asian (EAS)
AF:
0.489
AC:
2528
AN:
5170
South Asian (SAS)
AF:
0.605
AC:
2912
AN:
4812
European-Finnish (FIN)
AF:
0.760
AC:
8014
AN:
10550
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.703
AC:
47772
AN:
67990
Other (OTH)
AF:
0.679
AC:
1435
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1618
3235
4853
6470
8088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.717
Hom.:
7687
Bravo
AF:
0.712
Asia WGS
AF:
0.547
AC:
1903
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.4
DANN
Benign
0.66
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4236335;
hg19: chr7-33067130;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.